We studied the relationship of race to incidence of hospitalization for cerebrovascular disease among 74,096 white and 33,041 black persons who took health examinations in a prepaid health care program. Analyses were controlled for age, sex, body mass index, coffee use, smoking, alcohol use, systolic blood pressure, and baseline disease. Blacks were at higher hospitalization risk than whites for hemorrhagic cerebrovascular disease (relative risk=2.4, 95% confidence interval=1.3-5.8), cerebral thrombosis (relative risk=1.9, 95% confidence interval=1.2-2.9), and nonspecific cerebrovascular disease (relative risk=1.6, 95% confidence interval=1.2-2.2) but at lower hospitalization risk for extracranial occlusive disease (relative risk=0.4, 95% confidence interval=0.2-0.7). Blood pressure had a similar relation to all types of cerebrovascular disease in both races, but there were disparities in the relations of other atherosclerosis risk factors to different types of cerebrovascular disease. Educational attainment had little relation to hospitalization for extracranial occlusive disease, a finding that reduces the likelihood that selection bias explains the racial disparity. These data show unexplained racial differences in the type and location of cerebrovascular disease. The differences are important in understanding the pathogenesis of cerebrovascular disease and have practical clinical implications. (Stroke 1991^22:299-304)
"
3 This racial difference has generally been attributed to the higher prevalence among blacks of hypertension, 4 a powerful predictor of both hemorrhagic and occlusive stroke. There have also been reports 3 -5 ' 6 suggesting that, among occlusive cerebrovascular lesions, there is a black/ white disparity in the preponderant location of occlusions. These data suggest that white persons are more likely to develop occlusive disease of the large extracranial vessels (carotid, vertebral, basilar), while black persons are more likely to develop occlusions of the intracranial (especially the intracerebral) blood vessels. Racial differences in risk factors and in the causal patterns of arteriosclerosis in different types of cerebral arteries have been proposed as explanations for this disparity. One hypothesis 3 ' 7 is that blood lipid factors, less favorable in whites, might be more predictive of extracranial disease, while hypertension and diabetes, more prevalent in blacks, might be more predictive of intracranial occlusive disease. It has also been suggested 6 that socioeconomic factors related to the delivery of medical care lead to selection bias in the choice of patients who receive angiography and thus spuriously raise the apparent incidence of extracranial disease in whites relative to blacks. Clearly, further investigation is needed of these potentially important racial differences. We present pertinent data from a prospective study of hospitalizations for cerebrovascular disease in a large, racially diverse population.
Subjects and Methods
We studied 74,096 white persons and 33,041 black persons (total 107,137) who received multiphasic health examinations in a prepaid health plan from January 1978 through December 1984. The examination was, for most persons, a routine health appraisal. The procedure included questionnaires that elicited information about race, habits, health, and sociodemographic status as well as a panel of health measurements and laboratory tests. For individuals who had two or more examinations during the study years, we used baseline data from only the first examination. All subjects were followed up until they left the health plan or until December 1984, whichever occurred first. Gaps in membership of ^1 year were subtracted from the follow-up time. The procedure yielded 261,397 person-years of follow-up for white persons (mean 3.53 years per subject) and 119,696 person-years of follow-up for black persons (mean 3.62 years per subject). Hospitalizations for cerebrovascular disease (674 hospitalizations for 581 patients) were detected by computer search in the plan's hospitalization records for discharge diagnostic codes 430-438 of the International Classification of Diseases, Adapted for Use in the United States: Eighth Revision. 8 Subsets of stroke diagnosis included subarachnoid hemorrhage (code 430, n=23), cerebral hemorrhage (code 431, /i=46), occlusion of precerebral arteries (code 432, n = 124), cerebral thrombosis (code 433, « = 104), cerebral embolism (code 434, n=17), transient cerebral ischemia (code 435, «=63), acute but ill-defined cerebrovascular disease (code 436, n=241), generalized ischemic cerebrovascular disease (code 437, «=8), and other and ill-defined cerebrovascular disease (code 438, n=48). We classified as "hemorrhagic cerebrovascular disease" codes 430 and 431 (rc=69) and as "occlusive cerebrovascular disease" codes 432, 433, 434, and 435 (n=292; 16 of 292 subjects were hospitalized for more than one occlusive diagnosis, but only the first one was included in the analyses). Codes 436, 437, and 438 were included in some analyses as "nonspecific cerebrovascular disease" (n=274; 23 of 274 subjects were hospitalized for more than one nonspecific cerebrovascular disease). For analysis of each subset, follow-up of cases ended at the date of their first hospitalization for the specific category. All analyses used the Cox proportional hazards model and were controlled for age, sex, Quetelet's body mass index, coffee use, smoking, alcohol use, systolic blood pressure, and baseline disease (one or more of seven history items indicating cardiovascular disease or recent major illness). Some analyses were also controlled for total blood cholesterol concentration, blood sugar concentration, or educational attainment. For economy, we used an approximately 10% random sample of all persons not hospitalized for cerebrovascular disease (n = 10,390) as the comparison group.
After the initial data analysis, we reviewed a systematic sample of 50 cases of occlusive cerebrovascular disease; 41 (82%) records were obtainable. All but one of the 41 cases were judged to have occlusive cerebrovascular disease. Of 20 cases coded as having cerebral thrombosis, 19 (95%) actually had an occlusive stroke; the other was miscoded and actually had a cerebral hemorrhage. A striking finding among the cases coded as having occlusion of precerebral arteries was that 14 of the 15 cases reviewed (93%) were hospitalized, not for an acute neurologic episode, but for diagnosis or treatment of atherosclerotic extracrania] (usually carotid) artery occlusion. Since 40 (97.6%) of 41 occlusive cases reviewed actually had occlusive cerebrovascular disease, we did not carry this validation further, nor did we rerun the analyses for occlusive cerebrovascular disease.
We also undertook to validate one half of the cases of hemorrhagic cerebrovascular disease, but because of an obvious high error rate we enlarged this review to include all available charts. Of the 80 originally identified hemorrhagic cases, charts were available for 72 (90%). Of the 72 hemorrhagic cases reviewed, nine were found to be subdural hematomas or hygromas and two were probably nonhemorrhagic infarctions. Furthermore, one case classified as a cerebral hemorrhage was really a subarachnoid hemorrhage. All known errors were corrected, and all analyses of the hemorrhagic cerebrovascular disease subsets were rerun using the remaining 69 cases (80 minus 11).
It is not possible to assign responsibility for the coding errors we found. In most instances the final diagnosis was written by an internist or medical resident, and the code numbers were assigned by nonphysician personnel. Computed tomography was done in 89% (64) of the 72 reviewed cases originally classified as hemorrhagic and in 84% (16) of the 19 cases of cerebral thrombosis we reviewed. All reviewed cases coded as precerebral thrombosis had arteriograms.
Further description of the details of our methods, as well as characteristics of the cases of hemorrhagic cerebrovascular disease and the 10% random sample of all noncases, have been published. 
Results
Blacks, who comprised 30.8% of the study population, were overrepresented among the hemorrhagic cerebrovascular disease cases (31 of 69, 44.9%) and slightly underrepresented among the occlusive cerebrovascular disease cases (72 of 292 persons, 24.7%). The age-adjusted relative risk (RR) of hospitalization for hemorrhagic cerebrovascular disease was 2.64 (black versus white) with a 95% confidence interval (CI) of 1.62-4.30 (/xO.0001). A similarly elevated risk of hemorrhagic cerebrovascular disease among blacks was found in multivariate analyses (Table 1) . We found only minor variations in this racial difference in separate analyses of men, women, and persons free of baseline disease. Omitting control for blood pressure or adding control for blood cholesterol or blood sugar concentrations had only slight effects on the RRs. Blacks were at significantly higher risk than whites for both subarachnoid hemorrhage and cerebral hemorrhage ( Table 2) .
A small black versus white difference in hospitalization risk was found for all occlusive strokes combined in age-adjusted univariate analysis (RR=1.35, 95% CI=1.03-1.77,/>=0.03), but there were no significant race differences in any multivariate analyses (Table 1) . However, there were obvious differences in the proportions of the two races among the subsets of occlusive cerebrovascular disease. Blacks comprised 12.1% (15) of the 124 precerebral artery occlusion cases, 36.5% (38) of the 104 cerebral Table 2 ). The smaller subsets of occlusive cerebrovascular disease (cerebral embolism and transient cerebral ischemia) showed no significant racial differences in risk.
To explore the racial differences in risk of precerebral artery occlusion and cerebral thrombosis, we studied the relations of several established risk factors for atherosclerotic vascular disease to hospitalization for each of these diagnoses separately for whites and blacks (Table 3) . A consistent male versus female preponderance was found, slightly stronger in both races for cerebral thrombosis than for precerebral artery occlusion. Systolic blood pressure and blood glucose concentration had similar relations to both diagnostic subsets in both races. Total blood cholesterol concentration and smoking had stronger relations to precerebral artery occlusion than to cerebral thrombosis in whites but not in blacks. Smoking showed a clearly progressive dose-response relation only to precerebral artery occlusion in whites, but the risk was always lowest in those who had never smoked. The inverse relation of alcohol use to risk of hospitalization for either occlusive disease subset 9 appeared stronger among blacks than among whites.
Nonspecific cerebrovascular disease was diagnosed for 274 persons; blacks were at greater risk of hospitalization for this group of conditions in age-adjusted (RR=2.21, 95% CI=1.71-2.85,p<0.0001) or multivariate (Table 1) analysis. The racial difference in the risk of nonspecific cerebrovascular disease was substantially stronger for women than for men but was little related to blood pressure, baseline disease, blood cholesterol concentration, or blood glucose concentration. Baseline disease and systolic blood pressure showed relatively strong relations to risk for this group, while smoking, blood cholesterol concen- tration, blood glucose concentration, alcohol use, and educational attainment showed relatively weak associations (data not shown).
Analyses that included all 581 persons hospitalized for cerebrovascular disease showed RRs dominated by the disease subsets for which black persons are at higher risk. The age-adjusted RR for blacks compared with whites was 1.69 (95% CI= 1.40-2.02, /xO.0001); the RR in multivariate analysis was 1.33 (95% CI=1.09-1.52,/>=0.005).
The relations of other traits to hemorrhagic cerebrovascular disease can be briefly summarized. Age, blood pressure, and heavier (^3 drinks/day) alcohol use were related to all hemorrhagic cerebrovascular disease and to the cerebral hemorrhage subset, but none was significantly related to subarachnoid hemorrhage. Thus, black race was the strongest (and only significant) predictor of subarachnoid hemorrhage. Women were at lower risk of occlusive cerebrovascular disease (RR for women versus men for all occlusive cerebrovascular disease=0.6, 95% CI=0.5-0.7). The sex difference was less for hemorrhagic cerebrovascular disease (RR for women versus men=0.8, 95% CI=0.5-1.4) than for occlusive cerebrovascular disease, but there were slight (nonsignificant) disparities between races: for black women versus black men RR=0.6 (95% CI=0.3-1.3) and for white women versus white men RR=1.1 (95% CI=0.6-2.2).
Finally, as an indicator of socioeconomic status, we studied the relation of educational attainment to risk of hospitalization for precerebral artery occlusion and cerebral thrombosis (Table 4) . Persons with levels of educational attainment lower than college graduation were not at a significantly different risk of hospitalization for either subset. There was almost no relation of educational attainment to hospitalization for precerebral artery occlusion, and addition of the education variable had almost no effect on the RR for blacks compared with whites. 
Discussion
The higher prevalence of hypertension in blacks than in whites makes it reasonable to conclude that "hypertension related diseases of small intracerebral arteries, lacunar strokes, intracerebral hemorrhage, and multi-infarct dementia are also more common in blacks". 3 Our data partially support this statement in view of the higher risk of blacks for hemorrhagic, intracranial occlusive, and nonspecific ill-defined cerebrovascular disease. However, the race differences were independent of blood pressure in our analysis and were increased only slightly in the various cerebrovascular disease subsets when control for blood pressure was omitted from the analyses. It has also been postulated that uncontrolled hypertension is especially prevalent in black men 6 and is thus responsible for the high incidence of intracerebral hemorrhage in them. We did find a male preponderance of hemorrhagic cerebrovascular disease among blacks, but not among whites. However, there was only a slight racial difference in the male preponderance among patients hospitalized for cerebral thrombosis, and the male preponderance among persons hospitalized for nonspecific cerebrovascular disease was greater for whites. It is probable that the blood pressure of many subjects at the time of admission to the hospital for cerebrovascular disease differed from the value obtained at the baseline examination and used in the analyses. To have an effect on the race comparisons in our analyses, the disparities between baseline and admission blood pressures would have to be systematically related to race. While it is theoretically possible that systematic race differences occur in treatment advice, treatment compliance, or treatment response, we believe that the prepayment nature of the Kaiser Permanente Medical Care system minimizes the economic aspects of these potential problems. Blood pressure was recorded in all persons by a standardized procedure and showed strong relations in both races to precerebral artery occlusion and cerebral thrombosis (Table 3) and to hemorrhagic cerebrovascular disease. 9 These facts, plus the minor effect of blood pressure control (Table 1), reduce the likelihood that systematic racerelated blood pressure changes after baseline measurement are substantially involved in our findings. All in all, we conclude that the racial differences in hypertension, controlled or uncontrolled, are not likely to be the sole explanation for the higher risk we found among blacks for several types of cerebrovascular disease. Our data provide even less evidence that racial differences in blood glucose levels are involved in the racial disparities.
The most striking finding in our study is the black/white disparity in the risk of intracranial (blacks > whites) and extracranial (whites > blacks) occlusive cerebrovascular disease. As discussed in a previous publication, 9 most hospitalizations for precerebral artery occlusion were for carotid surgery rather than for acute neurologic syndromes. This fact raises the question of referral bias as the explanation for the racial difference. Such bias would result if consideration or acceptance of the primary diagnostic procedure for extracranial occlusive disease, invasive angiography, were related to race. Presumably sociocultural factors would be involved since we believe that economic considerations are not a factor in the selection of diagnostic tests in our prepaid health care program. We used educational attainment as a marker for sociocultural status and interpret the absence of a relation to hospitalization for precerebral artery occlusion as evidence against the referral bias hypothesis. We cannot resolve the question further. However, since our findings are in agreement with those of other studies, 3 -3 ' 6 it seems appropriate to seek other explanations.
Since extracranial vascular disease is believed to be highly correlated with atherosclerotic coronary and peripheral vascular occlusion, 3 we should expect to find especially strong associations with risk factors for coronary artery disease. Our data partially support this hypothesis, at least in whites, since total blood cholesterol concentration and smoking show slightly stronger associations in whites with precerebral artery occlusion than in those with cerebral thrombosis. However, racial differences in the strength of the relations to risk factors for occlusive cerebrovascular disease subsets (Table 3) are relatively small and seem inadequate to account for the racial difference in hospitalization risk. In a previous report 11 we presented data about predictors of coronary artery disease hospitalizations in a substantial subset of this study population. The RR by sex was similar for coronary artery disease hospitalization (RE. women versus men=0.34, p<0.001) and precerebral artery occlusion hospitalization in this report, but there was no racial difference in the risk of coronary artery disease hospitalization (RR black versus white=1.02, p=0.84). Thus, we conclude that characteristics other than the standard coronary risk factors are primarily responsible for the racial disparities in hospitalization for occlusive cerebrovascular disease.
The racial differences reported here resemble those between whites and Japanese. Epidemiologic studies among Japanese men in Japan, Hawaii, and California have shown marked disparities between the incidence and trends of coronary artery disease and stroke. 12 - 13 Similar distributions of vascular disease have been reported in blacks and Japanese 10 in a study that demonstrated significant differences between Japanese and white US populations with cerebrovascular disease syndromes. A possible role of animal protein has been postulated, with a relative deficiency contributing to an increase in intracerebral disease. 13 If US blacks ingested less protein than whites, this mechanism could be involved.
Assuming that the racial differences we found are valid, the theoretical importance of the differences for understanding cerebrovascular disease pathogenesis seems obvious. We suspect that the racial differences are not widely appreciated by clinicians. The impor-tance of race consciousness in medical diagnosis is gaining increasing recognition. 14 The initial assessment and diagnostic plans in cerebrovascular disease syndromes should consider the likelihood of disease in specific locations. Thus, as Caplan and Cooper 3 point out, angiography and computed tomography may be relatively more useful in black persons because of the higher prevalence in blacks of intracranial occlusions and hemorrhages. By similar reasoning, the lower prevalence of extracranial disease in black persons makes noninvasive tests, such as continuous-wave Doppler imaging and venous digital subtraction angiography, less useful than in white persons. It is also possible that aspirin and other antithrombotic treatments may be less useful in black persons, 3 but data supporting this speculation are not available. In conclusion, race should be one of the factors considered by clinicians making decisions about the management of cerebrovascular disease syndromes.
